Feedback / Questions
IMNN-001 - Imunon
https://www.globenewswire.com/news-release/2024/05/15/2882430/0/en/Abstract-on-Phase-2-Study-with-IMUNON-s-IMNN-001-Plus-Bevacizumab-Accepted-for-Presentation-at-the-American-Society-of-Clinical-Oncology-Annual-Meeting.html
May 15, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next